Literature DB >> 23984019

Recurrent Urinary Tract Infections Management in Women: A review.

Ahmed Al-Badr1, Ghadeer Al-Shaikh.   

Abstract

Urinary tract infections (UTIs) are one of the most frequent clinical bacterial infections in women, accounting for nearly 25% of all infections. Around 50-60% of women will develop UTIs in their lifetimes. Escherichia coli is the organism that causes UTIs in most patients. Recurrent UTIs (RUTI) are mainly caused by reinfection by the same pathogen. Having frequent sexual intercourse is one of the greatest risk factors for RUTIs. In a subgroup of individuals with coexisting morbid conditions, complicated RUTIs can lead to upper tract infections or urosepsis. Although the initial treatment is antimicrobial therapy, use of different prophylactic regimens and alternative strategies are available to reduce exposure to antibiotics.

Entities:  

Keywords:  Antibiotic Prophylaxis; Prevention; Urinary Tract Infection, therapy

Year:  2013        PMID: 23984019      PMCID: PMC3749018          DOI: 10.12816/0003256

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  79 in total

1.  Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.

Authors:  A J Schaeffer; B A Stuppy
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 3.  Prevention of urinary tract infection.

Authors:  A Stapleton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

4.  A five-year prospective follow-up of women with non-obstructive pyelonephritic renal scarring.

Authors:  S H Jacobson
Journal:  Scand J Urol Nephrol       Date:  1991

Review 5.  Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women.

Authors:  J D Engel; A J Schaeffer
Journal:  Urol Clin North Am       Date:  1998-11       Impact factor: 2.241

Review 6.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

7.  Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women.

Authors:  A Aune; T Alraek; H LiHua; A Baerheim
Journal:  Scand J Prim Health Care       Date:  1998-03       Impact factor: 2.581

Review 8.  Urinary tract infection: traditional pharmacologic therapies.

Authors:  Lindsay E Nicolle
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

Review 9.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

10.  Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells.

Authors:  D Zafriri; I Ofek; R Adar; M Pocino; N Sharon
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

View more
  34 in total

Review 1.  Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.

Authors:  Valerie P O'Brien; Thomas J Hannan; Anthony J Schaeffer; Scott J Hultgren
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

2.  Modified horseshoe crab peptides target and kill bacteria inside host cells.

Authors:  Anna S Amiss; Jessica B von Pein; Jessica R Webb; Nicholas D Condon; Peta J Harvey; Minh-Duy Phan; Mark A Schembri; Bart J Currie; Matthew J Sweet; David J Craik; Ronan Kapetanovic; Sónia Troeira Henriques; Nicole Lawrence
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

Review 3.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

Review 4.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

5.  Comparative Study of ESBL Production Among Uropathogenic Escherichia coli Clinical Isolates from Pre- and Post-menopausal Women in Egypt.

Authors:  Ghada Hani Ali; Marwa A Yakout
Journal:  Curr Microbiol       Date:  2021-07-20       Impact factor: 2.188

6.  Local induction of bladder Th1 responses to combat urinary tract infections.

Authors:  Jianxuan Wu; Chunjing Bao; R Lee Reinhardt; Soman N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

Review 7.  Recurrent urinary tract infections in women.

Authors:  Abdullatif Aydin; Kamran Ahmed; Iftikhar Zaman; Muhammad Shamim Khan; Prokar Dasgupta
Journal:  Int Urogynecol J       Date:  2014-11-20       Impact factor: 2.894

8.  Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection.

Authors:  Ivy Y Ge; Helene B Fevrier; Carol Conell; Malika N Kheraj; Alexander C Flint; Darvin S Smith; Lisa J Herrinton
Journal:  Ther Adv Urol       Date:  2018-06-22

9.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18

10.  Subtyping β-lactamase-producing Escherichia coli strains isolated from patients with UTI by MLVA and PFGE methods.

Authors:  Alireza Dolatyar Dehkharghani; Setareh Haghighat; Marjan Rahnamaye Farzami; Masoumeh Douraghi; Mohammad Rahbar
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.